Whole genome sequence of Enterococcus gallinarum EG81, a porcine strain harbouring the oxazolidinone-phenicol resistance gene optrA with chromosomal and plasmid location

Tian-Ge Yao,Bo-Yang Li,Ren-Dong Luan,Hong-Ning Wang,Chang-Wei Lei
DOI: https://doi.org/10.1016/j.jgar.2020.06.012
IF: 4.349
2020-09-01
Journal of Global Antimicrobial Resistance
Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Objectives</h3><p>The aim of this study was to characterise the whole genome sequence of linezolid-intermediate <em>Enterococcus gallinarum</em> strain EG81 of swine origin in China.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>Whole genome of EG81 was sequenced using Illumina MiSeq platform combining with Nanopore PromethION platform, and assembled <em>de novo</em> using Canu v1.5. NCBI Prokaryotic Genome Annotation Pipeline (PGAP) was used to annotate the genome of EG81. Antimicrobial resistance genes were identified using CGE ResFinder 3.2.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>The genome of EG81 consists of one 3,433,237 bp chromosome and two plasmids, pEG81-1 (51,632 bp) and pEG81-2 (3,425 bp). A total of 3285 coding sequences and 80 RNA genes were predicted by PGAP. Oxazolidinone-phenicol resistance gene <em>optrA</em> is located on both chromosome and plasmid pEG81-1 associated with Tn<em>554</em> and Tn<em>558</em>, respectively. In addition, EG81 harbors <em>vanC1XY</em> (vancomycin resistance), <em>fexA</em> (phenicol), <em>dfrG</em> (trimethoprim), <em>aadD</em>, <em>ant(6)-Ia</em> and <em>ant(9)-Ia</em> (aminoglycoside), <em>erm(A)</em> and <em>erm(B)</em> (macrolide), <em>tet</em>(L) and <em>tet</em>(M) (tetracycline).</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusion</h3><p>Here we first report the oxazolidinone-phenicol gene <em>optrA</em> in <em>E. gallinarum</em> that is intrinsically resistant to vancomycin, which poses great threat to public health. The genome sequence of <em>E. gallinarum</em> EG81 provides valuable information for the dissemination of <em>optrA</em> among vancomycin-resistant enterococci.</p>
pharmacology & pharmacy,infectious diseases
What problem does this paper attempt to address?